From: The C18:3n6/C22:4n6 ratio is a good lipid marker of chronic kidney disease (CKD) progression
Characteristic | Women n = 62 Avg + SD | Men n = 87 Avg + SD | Significance of differences |
---|---|---|---|
Age ([years)] | 65.88 ± 13.98 | 63.40 ± 15.90 | NS |
Weight ([kg)] | 69.33 ± 18.47 | 76.60 ± 15.97 | 0.0479 |
BMI [kg/m2] | 24.81 ± 6.14 | 25.28 ± 6.6 | NS |
Ca [mg/dl] | 8.66 ± 0.97 | 8.47 ± 0.79 | NS |
I PHOS [mg/dl] | 5.375 ± 1.36 | 5.03 ± 1.26 | NS |
iPTH [pg/ml] | 705.8 ± 663.9 | 416.2 ± 364.7 | 0.0097 |
CREA [mg/dl] | 7.49 ± 2.07 | 8.41 ± 2.35 | NS |
HGB [g/dl] | 10.67 ± 1.11 | 10.74 ± 1.37 | NS |
%TSAT [%] | 30.57 ± 15.22 | 29.24 ± 13.29 | NS |
FER [ug/l] | 954,9 ± 739.5 | 689.2 ± 616.9 | 0.0000 |
ALB [g/l] | 34.56 ± 4.31 | 35.80 ± 3.92 | NS |
K [mEq/L] | 5.347 ± 0.64 | 5.261 ± 0.63 | NS |
Treatment duration [months] | 62.42 ± 79.38 | 46.29 ± 52.01 | NS |
Body surface [m2] | 1.727 ± 0.21 | 1.846 ± 0.186 | 0.0074 |
Kt/V | 1.716 ± 0.31 | 1.579 ± 0.33 | 0.0136 |
nPCR [g/kg/day] | 1.071 ± 0.24 | 1.09 ± 0.267 | NS |
Ca x P [mg2/dl2] | 47.18 ± 11.63 | 42.096 ± 12.457 | NS |